相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perception of hematologists and oncologists about the biosimilars: A prospective Tunisian study based on a survey
Selma Hadoussa et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
Vesa Halimi et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Potential Cost-Savings From the Use of the Biosimilars in Slovakia
Tomas Tesar et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions
Charles L Bennett et al.
LANCET ONCOLOGY (2020)
Biosimilars in oncology: Effects on economy and therapeutic innovations
Kai Huebel et al.
EUROPEAN JOURNAL OF CANCER (2020)
Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
Rosa Giuliani et al.
ESMO OPEN (2019)
Academic oncology clinicians' understanding of biosimilars and information needed before prescribing
John W. Cook et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Biosimilar Knowledge Among Oncology/Hematology Team Members in Colorado, USA: An Educational Initiative and Follow-Up Survey
Rovshan M. Ismailov et al.
BIODRUGS (2018)
The health economics of cancer screening in Germany: Which population-based interventions are cost-effective?
Michael Schlander et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2018)
Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians
Hillel Cohen et al.
ADVANCES IN THERAPY (2017)
Japanese regulation of biosimilar products: past experience and current challenges
Teruyo Arato
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The economic pressures for biosimilar drug use in cancer medicine
Paul Cornes
TARGETED ONCOLOGY (2012)
分享论文
